For: | Jun YJ, Jang SM, Han HL, Lee KH, Jang KS, Paik SS. Clinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas. World J Gastroenterol 2011; 17(14): 1866-1873 [PMID: 21528061 DOI: 10.3748/wjg.v17.i14.1866] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i14/1866.htm |
Number | Citing Articles |
1 |
Sandra Fernandes Martins, Ricardo Amorim, Marta Viana-Pereira, Céline Pinheiro, Ricardo Filipe Alves Costa, Patrícia Silva, Carla Couto, Sara Alves, Sara Fernandes, Sónia Vilaça, Joaquim Falcão, Herlander Marques, Fernando Pardal, Mesquita Rodrigues, Ana Preto, Rui Manuel Reis, Adhemar Longatto-Filho, Fátima Baltazar. Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2566-9
|
2 |
Jin-Qiang Chen, Jose Russo. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2012; 1826(2): 370 doi: 10.1016/j.bbcan.2012.06.004
|
3 |
Min-Hsun Kuo, Wen-Wei Chang, Bi-Wen Yeh, Yeh-Shiu Chu, Yueh-Chun Lee, Hsueh-Te Lee. Glucose Transporter 3 Is Essential for the Survival of Breast Cancer Cells in the Brain. Cells 2019; 8(12): 1568 doi: 10.3390/cells8121568
|
4 |
Huabin Gao, Jiangtao Liang, Jing Duan, Lin Chen, Hui Li, Tiantian Zhen, Fenfen Zhang, Yu Dong, Huijuan Shi, Anjia Han. A Prognosis Marker SLC2A3 Correlates With EMT and Immune Signature in Colorectal Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.638099
|
5 |
Andreas Koch, Sven Arke Lang, Peter Johannes Wild, Susanne Gantner, Abdo Mahli, Gerrit Spanier, Mark Berneburg, Martina Müller, Anja Katrin Bosserhoff, Claus Hellerbrand. Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells. Oncotarget 2015; 6(32): 32748 doi: 10.18632/oncotarget.4977
|
6 |
Jing Yang, Jing Wen, Tian Tian, Zhongsheng Lu, Yao Wang, Zikai Wang, Xiangdong Wang, Yunsheng Yang. GLUT-1 overexpression as an unfavorable prognostic biomarker in patients with colorectal cancer. Oncotarget 2017; 8(7): 11788 doi: 10.18632/oncotarget.14352
|
7 |
Wen-bo Long, Xia Pu, Yi Tang, Ming Li, Yun Liu, Qin She, Ya-lan Wang, Qin-xi Guo. Arginine ADP-ribosyltransferase 1 Regulates Glycolysis in Colorectal Cancer via the PI3K/AKT/HIF1α Pathway. Current Medical Science 2022; 42(4): 733 doi: 10.1007/s11596-022-2606-4
|
8 |
Ryuichi Ito, Masakazu Yashiro, Takuma Tsukioka, Nobuhiro Izumi, Hiroaki Komatsu, Hidetoshi Inoue, Noritoshi Nishiyama. Usefulness of pyruvate dehydrogenase-E1α expression to determine SUVmax cut-off value of [18F]FDG-PET for predicting lymph node metastasis in lung cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-28805-8
|
9 |
Pablo Azcue, David Guerrero Setas, Ignacio Encío, Berta Ibáñez-Beroiz, María Mercado, Ruth Vera, María Luisa Gómez-Dorronsoro. A Novel Prognostic Biomarker Panel for Early-Stage Colon Carcinoma. Cancers 2021; 13(23): 5909 doi: 10.3390/cancers13235909
|
10 |
Li Song, Chunyan Zhu, Qing Shi, Yuhan Xia, Xiayi Liang, Wen Qin, Tao Ye, Biwei Yang, Xin Cao, Jinglin Xia, Kun Zhang. Gelation embolism agents suppress clinical TACE-incited pro-metastatic microenvironment against hepatocellular carcinoma progression. eBioMedicine 2024; 109: 105436 doi: 10.1016/j.ebiom.2024.105436
|
11 |
Noha M. El-Kady, Abd El-Naby S. Mohamed, Hayam A. Aiad, Moshira M. Abd El-Wahed, Nancy Y. Asaad, Dina M. Allam. Evaluation of the role of HIF-1α and GLUT-1 in the pathogenesis of ovarian surface epithelial tumors and their prognostic impact. Egyptian Journal of Pathology 2018; 38(1): 110 doi: 10.1097/01.XEJ.0000542233.99011.a6
|
12 |
G. Ariaans, S. de Jong, J.A. Gietema, J.D. Lefrandt, E.G.E. de Vries, M. Jalving. Cancer-drug induced insulin resistance: Innocent bystander or unusual suspect. Cancer Treatment Reviews 2015; 41(4): 376 doi: 10.1016/j.ctrv.2015.02.007
|
13 |
Saniye ADA, Cemre ERTÜRK, Aylin UÇAR, Süleyman AKYÜZ, Fatma DOĞAN, Burcu YÜCEL. KANSER HÜCRE METABOLİZMASI. Türkiye Sağlık Enstitüleri Başkanlığı Dergisi 2021; 4(3): 66 doi: 10.54537/tusebdergisi.981144
|
14 |
Josipa Kokeza, Ante Strikic, Marin Ogorevc, Nela Kelam, Martina Vukoja, Ivo Dilber, Sandra Zekic Tomas. The Effect of GLUT1 and HIF-1α Expressions on Glucose Uptake and Patient Survival in Non-Small-Cell Lung Carcinoma. International Journal of Molecular Sciences 2023; 24(13): 10575 doi: 10.3390/ijms241310575
|
15 |
Xiaotong Chen, Yunshuo Zhao, Sifan Lyu, Guanfei Gao, Yanfeng Gao, Yuanming Qi, Jiangfeng Du. Identification of novel inhibitors of GLUT1 by virtual screening and cell-based assays. Investigational New Drugs 2021; 39(5): 1242 doi: 10.1007/s10637-021-01109-2
|
16 |
Smreti Vasudevan, Anurag Mehta, Sanjeev Kumar Sharma, Anurag Sharma. Expression of glucose transporter 1 (SLC2A1) – Clinicopathological associations and survival in an Indian cohort of colorectal cancer patients. Journal of Cancer Research and Therapeutics 2022; 18(3): 650 doi: 10.4103/jcrt.jcrt_42_21
|
17 |
Andrus Kaldma, Aleksandr Klepinin, Vladimir Chekulayev, Kati Mado, Igor Shevchuk, Natalja Timohhina, Kersti Tepp, Manana Kandashvili, Minna Varikmaa, Andre Koit, Margus Planken, Karoliina Heck, Laura Truu, Anu Planken, Vahur Valvere, Egle Rebane, Tuuli Kaambre. An in situ study of bioenergetic properties of human colorectal cancer: The regulation of mitochondrial respiration and distribution of flux control among the components of ATP synthasome. The International Journal of Biochemistry & Cell Biology 2014; 55: 171 doi: 10.1016/j.biocel.2014.09.004
|
18 |
Hyun-A Yang, Tae-Hee Han, Keeok Haam, Kyung-Soo Lee, Jinsu Kim, Tae-Su Han, Moo-Seung Lee, Hyun Seung Ban. Prodigiosin regulates cancer metabolism through interaction with GLUT1. Natural Product Research 2024; : 1 doi: 10.1080/14786419.2024.2367241
|
19 |
Xiaotong Chen, Yunshuo Zhao, Chuanjie He, Guanfei Gao, Jiao Li, Lu Qiu, Xiaoxi Wang, Yanfeng Gao, Yuanming Qi, Kai Sun, Jiangfeng Du. Identification of a novel GLUT1 inhibitor with in vitro and in vivo anti-tumor activity. International Journal of Biological Macromolecules 2022; 216: 768 doi: 10.1016/j.ijbiomac.2022.07.123
|
20 |
Tae Hyun Kim, Yoonjin Kwak, Changhoon Song, Hye Seung Lee, Duck-Woo Kim, Heung-Kwon Oh, Jin Won Kim, Keun-Wook Lee, Sung-Bum Kang, Jae-Sung Kim. GLUT-1 may predict metastases and death in patients with locally advanced rectal cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1094480
|
21 |
Fan Jiang, Zhiju Chen, Xiang Wang, Chuangyu Huang, Yiwei Li, Ning Liu.
Activation of the WNT7B/β-Catenin Pathway Initiates
GLUT1
Expression and Promotes Aerobic Glycolysis in Colorectal Cancer Cells
. Nutrition and Cancer 2025; 77(2): 311 doi: 10.1080/01635581.2024.2418607
|
22 |
Iñigo San-Millán, George A. Brooks. Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect. Carcinogenesis 2016; : bgw127 doi: 10.1093/carcin/bgw127
|
23 |
Zizhen Wu, Bo Wang, Yingjiang Ye, Shan Wang, Kewei Jiang. Development and verification of a prognostic model for colon cancer on pyroptosis-related genes. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.922055
|
24 |
Angara Zambrano, Matías Molt, Elena Uribe, Mónica Salas. Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy. International Journal of Molecular Sciences 2019; 20(13): 3374 doi: 10.3390/ijms20133374
|
25 |
Jongmin Sim, Kijong Yi, Hyunsung Kim, Hyein Ahn, Yumin Chung, Abdul Rehman, Se Min Jang, Kang Hong Lee, Kiseok Jang, Seung Sam Paik. Immunohistochemical Expression of Dual-Specificity Protein Phosphatase 4 in Patients with Colorectal Adenocarcinoma. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/283764
|
26 |
Hanjie Yi, Yongqin Han, Qin Li, Runduan Lin, Jia Zhang, Yun Yang, Xueping Wang, Lin Zhang. Prognostic impact of the combination of HIF‑1α and GLUT1 in patients with oesophageal squamous cell carcinoma. Oncology Letters 2023; 26(3) doi: 10.3892/ol.2023.13990
|
27 |
Kehinde Adekola, Steven T. Rosen, Mala Shanmugam. Glucose transporters in cancer metabolism. Current Opinion in Oncology 2012; 24(6): 650 doi: 10.1097/CCO.0b013e328356da72
|
28 |
Anna Choromańska, Jolanta Saczko, Sandra Łubińska, Anna Szewczyk, Julita Kulbacka. WITHDRAWN: Mechanisms of antimelanoma effect of oat β-glucan supported by electroporation. Bioelectrochemistry 2018; doi: 10.1016/j.bioelechem.2018.01.003
|
29 |
Aliaa A Alamoudi, Amina Alnoury, Hoda Gad. miRNA in tumour metabolism and why could it be the preferred pathway for energy reprograming. Briefings in Functional Genomics 2018; 17(3): 157 doi: 10.1093/bfgp/elx023
|
30 |
YUHO MAKI, JUNICHI SOH, KOUICHI ICHIMURA, KAZUHIKO SHIEN, MASASHI FURUKAWA, TAKAYUKI MURAOKA, NORIMITSU TANAKA, TSUYOSHI UENO, HIROMASA YAMAMOTO, HIROAKI ASANO, KAZUNORI TSUKUDA, SHINICHI TOYOOKA, SHINICHIRO MIYOSHI. Impact of GLUT1 and Ki-67 expression on early-stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification. Oncology Reports 2013; 29(1): 133 doi: 10.3892/or.2012.2087
|
31 |
GhadaM. K GabAllah, MonaSalah El-din Habib, ShimaaEl-Shafey Soliman, ZienabA Kasemy, SuzyF Gohar. Validity and clinical impact of glucose transporter 1 expression in colorectal cancer. Saudi Journal of Gastroenterology 2017; 23(6): 348 doi: 10.4103/sjg.SJG_197_17
|